SRPT

#1698
Sarepta Therapeutics, Inc. - Common Stock
17.8 7 USD
+3.24%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
17.87
17.87
Year Range
10.41
43.91
Daily Change
+3.24%
Monthly Change
-14.78%
6 month change
-14.74%
Year Change
-53.04%
Previous Close
17.3 1
Open
17.8 7
Low
17.8 7
High
17.8 7
Volume
188
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 1.89 B
  • Employee 835
  • Founded 1980
  • CEO Douglas S. Ingram
  • Website www.sarepta.com
  • Headquarter Delaware, United States
  • FIGI BBG000BCJ161
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.02
Price to sales ratio
0.98

Sarepta Therapeutics, Inc. - Common Stock

Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs.

News